BSE · 541601
Rajnish Wellness Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹49 Cr with net profit ₹0 Cr — a 0.35% net margin, versus 1.35% the period before.
Shareholding
As of 2026-06-30
- Promoter9.16%
- Public90.41%
- FII0.43%
1,58,442 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.23× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pharmaceuticals - Indian - Bulk Drugs & Formln · ranked #81 of 102 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | ₹4,80,131 Cr | 38.63 | 5.75 | 13.74% | 19.72% |
| Cipla Ltd. | ₹1,18,462 Cr | 213.45 | 3.44 | 11.27% | 14% |
| Zydus Lifesciences Ltd. | ₹1,11,232 Cr | 20.48 | 4.1 | 18.59% | 18.86% |
| Lupin Limited | ₹1,10,705 Cr | 19.46 | 4.93 | 23.76% | 19.4% |
| Mankind Pharma Limited | ₹1,06,384 Cr | 52.81 | 6.53 | 11.74% | 13.4% |
| Laurus Labs Limited | ₹96,246 Cr | 88.01 | 18.16 | 16.77% | 15.04% |
| Dr Reddys Laboratories Ltd. | ₹95,553 Cr | 432 | 2.52 | 0.11% | 0.12% |
| Aurobindo Pharma Ltd. | ₹91,552 Cr | 99.39 | 2.42 | 9.25% | 10.5% |
| Alkem Laboratories Ltd. | ₹69,545 Cr | 294.21 | 5.03 | 16.66% | 15.65% |
| Biocon Ltd. | ₹69,034 Cr | 539.11 | 2.03 | 1.14% | 2.3% |
| Rajnish Wellness Limited(this company) | ₹43 Cr | — | 0.42 | -6.13% | -3.76% |
AI analysis
AI-generated · google/gemini-2.5-flashRajnish Wellness Limited has a market capitalization of Rs 42 Cr. The company reported revenue of Rs 49.08 ক্র in the most recent fiscal year and a profit margin of -376%. The debt-to-equity ratio stands at 0.03, and the book value per share is Rs 1.01. Return on equity and return on capital employed are -6.13% and -7.99% respectively.
Positives
- +The debt-to-equity ratio is low at 0.03.
- +Promoter pledge is 0%, indicating no shares are pledged by the promoters.
Negatives
- −The company reported a negative profit margin of -376%.
- −Return on equity is negative at -6.13%.
- −Return on capital employed is negative at -7.99%.
- −Promoter holding is low at 9.1615%.
- −Revenue for the fiscal year ending March 2025 was Rs 49.08 crore, a decrease from Rs 76.68 crore in March 2024.
- −Quarterly results are not disclosed since Mar 2026.
Financial Performance
Rajnish Wellness Limited's revenue for the fiscal year ending March 2025 was Rs 49.08 crore, a decrease from Rs 76.68 crore in March 2024. The net profit for March 2025 was Rs 0.17 crore, down from Rs 1.03 crore in March 2024. The company's most recent quarterly revenue (Mar 2026) was Rs 101.95 crore, with a net loss of Rs -4.7 crore.
Profitability & Returns
The company's profit margin is -376%. Return on equity (ROE) is -6.13%, and return on capital employed (ROCE) is -7.99%. Earnings per share (EPS) for the fiscal year ending March 2025 was Rs 0.0023, while the trailing EPS is Rs 0. For the quarter ending March 2026, the company reported a net loss per share.
Balance Sheet
Rajnish Wellness Limited has a book value per share of Rs 1.01. The debt-to-equity ratio is 0.03, indicating a low level of debt relative to equity. The company does not offer a dividend, with a dividend yield of 0%.
Ownership & Pledges
Promoter holding in Rajnish Wellness Limited is 9.1615% as of June 30, 2026. Public shareholding stands at 90.4101%, and institutional shareholding (FIIs) is 0.4284%. There are no shares pledged by the promoters.
Regulatory & Surveillance
The company is not currently under any specific surveillance measures. No historical surveillance data was provided.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.